I have a client that has a version of a medical device tested to meet 60601-1 2nd edition. That's right - 2nd edition. They want to ship out that product for "Evaluations" in clinical settings, some evaluations with IRBs, some perhaps not. Also some for "demos" by sales reps. The head of engineering and I are both uncomfortable with this approach.
They also said that they received a 510(k) right at the deadline for the 2nd edition and were granted a waiver to sell the products for 5 or 10 years. Has anyone heard of this?
This is not my area of expertise so comments and guidance are greatly appreciated.
Hi,
First off, 510(k) - The transition deadline was some years back (2013 if I'm not mistaken). It's possible that they got cleared earlier, but not likely if their 510(k) is recent. It should be easy to verify. "Waiver" - none is needed. There is no FDA requirement to "move with the times". Once a 510(k) is cleared there's no need to upgrade to newer versions - the clearance is indefinite, unless the design changes significantly.
back to your general situation - there's a regulatory aspect and a general engineering / risk management aspect.
The regulatory aspect is simple - you need to look at where the device is going to be used and see what the applicable requirements are. I wouldn't take it for granted that 3rd edition compliance is required everywhere, for every purpose.
From the general aspect - 2nd edition is not that "bad". I believe that it still holds significant value. It is up to careful analysis and judgement. I would look to understand what exactly is planned under "evaluations in clinical settings", "evaluations by IRBs" and "demos by sales reps". The biggest question is: Will it be used on humans? As for basic safety for operators/demonstrators, I would tend to think that full certified compliance with the 2nd edition provides a reasonable safety assurance, but I know nothing about the device.
Cheers,
Ronen.